. 2018 Nov 14;24:8190–8197. doi: 10.12659/MSM.912643

Table 2.

Clinicopathologic variables and KIF22 expression in 114 prostate cancer patients.

Variable	Group	KIF22 expression			P value^#
Variable	Group	n	High	Low	P value^#
Age	<70	64	40 (62.5%)	24 (37.5%)	0.541
Age	≥70	50	34 (68.0%)	16 (32.0%)	0.541
Perioperative PSA	≤10	49	16 (51.5%)	10 (38.5%)	0.682
Perioperative PSA	>10	65	58 (65.9%)	30 (34.1%)	0.682
Clinical stage	T1	55	30 (54.5%)	25 (45.5%)	0.025^*
Clinical stage	T2–3	59	44 (74.6%)	15 (25.4%)	0.025^*
Gleason score	<7	63	33 (52.4%)	30 (47.6%)	0.002^*
Gleason score	≥7	51	41 (80.4%)	10 (19.6%)	0.002^*
Seminal vesicle invasion	Absence	24	10 (41.7%)	14 (58.3%)	0.007^*
Seminal vesicle invasion	Presence	90	64 (71.1%)	26 (28.9%)	0.007^*
Lymph node metastasis	Absence	39	19 (48.7%)	20 (51.3%)	0.009^*
Lymph node metastasis	Presence	75	55 (73.3%)	20 (26.7%)	0.009^*

P value was analyzed by chi-square test;

indicates P<0.05 with statistical significance.